Behrang Kianzad
Postdoc
JUR Centre for Advanced Studies in Biomedical Innovation Law
Karen Blixens Plads 16, 2300 København S, 6B Bygning 6B, Building: 6B-3-04
The research proposal highlights the hotly debated issue of excessive pricing in the field of pharmaceuticals as an anti-competitive practice within European Competition Law & TRIPS.
The thesis conducts an investigation of the triangular dilemma of Intellectual Property Rights, Competition Law as well as Law & Economics. The questions to be answered are mainly “how much is too much” and “how to define excessiveness” in order to have both a legal as well as economically sound approach to alleged excessive price cases in the pharmaceutical sector.
Further questions to be answered are what constitutes a “fair price” and if “fairness” can be translated into administrable legal standard in relation to the goals of Competition Law as well as Intellectual Property Law.
Teaching
Behrang Kianzad teaches master-level courses in EU Intellectual Property Law, Life Science Law as well as EU Competition Law at the Faculty of Law, Copenhagen University.
ID: 182567918
Most downloads
-
39
downloads
Legal Remedies In Times of Global Pandemic Crisis-Price Gouging, Compulsory Licensing and the role of Antitrust
Research output: Contribution to conference › Paper › Research
Published -
10
downloads
‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19
Research output: Contribution to journal › Journal article › peer-review
Published